Lesson plan

Jochen Reiser

Jochen Reiser (born June 23, 1971, in Remchingen, Germany) is a physician-scientist-executive, Professor (John Sealy School of Medicine ), the John D. Stobo, MD Distinguished Chair, a healthcare leader, and a biotechnology company co-founder. He is the President of the University of Texas Medical Branch (UTMB) and CEO of the UTMB Health System, which includes the oldest medical school and nursing school in Texas. He oversees the enterprise which includes multiple campuses, five health science colleges, the Galveston National Laboratory (BSL-4) and the Correctional Health Care Services for most of Texas. Prior to joining the University of Texas Medical Branch, he served as the Ralph C Brown Professor and the Chairman of Medicine at Rush University Medical Center. Reiser's research has provided important mechanistic insights into the molecular pathogenesis of kidney diseases. Reiser discovered the role of suPAR (soluble urokinase plasminogen activator receptor) as a global, circulating risk factor for chronic kidney disease (CKD) and for acute kidney injury (AKI). suPAR is investigated as potential causative agent contributing to many kidney diseases including focal segmental glomerulosclerosis (FSGS).…

Back to article

Article summary

Jochen Reiser (born June 23, 1971, in Remchingen, Germany) is a physician-scientist-executive, Professor (John Sealy School of Medicine ), the John D. Stobo, MD Distinguished Chair, a healthcare leader, and a biotechnology company co-founder. He is the President of the University of Texas Medical Branch (UTMB) and CEO of the UTMB Health System, which includes the oldest medical school and nursing school in Texas. He oversees the enterprise which includes multiple campuses, five health science colleges, the Galveston National Laboratory (BSL-4) and the Correctional Health Care Services for most of Texas. Prior to joining the University of Texas Medical Branch, he served as the Ralph C Brown Professor and the Chairman of Medicine at Rush University Medical Center. Reiser's research has provided important mechanistic insights into the molecular pathogenesis of kidney diseases. Reiser discovered the role of suPAR (soluble urokinase plasminogen activator receptor) as a global, circulating risk factor for chronic kidney disease (CKD) and for acute kidney injury (AKI). suPAR is investigated as potential causative agent contributing to many kidney diseases including focal segmental glomerulosclerosis (FSGS).…

Key claims

  1. date of birth: 1971-06-23 — source: Wikipedia, revision 1372020741, retrieved 2026-10-20 · confidence 0.95

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. The record states that the date of birth is "1971-06-23". What evidence would count against this claim?
  3. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  4. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.